U.S. Banks Stock News

NYSE:BIO
NYSE:BIOLife Sciences

Elliott Stake Puts Bio-Rad Turnaround Plans And Sartorius Holding In Focus

Elliott Investment Management has built a significant stake in Bio-Rad Laboratories (NYSE:BIO). The activist position signals potential pressure for changes in operations, governance, or portfolio structure. This development comes as Bio-Rad’s shares trade at $281.05 and the company holds a sizable stake in Sartorius. For investors tracking NYSE:BIO, Elliott’s move lands on top of a mixed share price record, with the stock up 16.3% over the past week and 13.8% over the past year, but down...
NasdaqCM:HOVR
NasdaqCM:HOVRAerospace & Defense

Assessing New Horizon Aircraft (HOVR) Valuation After New Equity Raise And Hybrid Electric VTOL Updates

Why New Horizon Aircraft’s latest equity raise matters for investors New Horizon Aircraft (NasdaqCM:HOVR) has just completed a registered direct follow on equity offering of about US$19.9 million, selling 9,254,889 Class A ordinary shares at US$2.15, a US$0.1505 discount per share. This capital raise, alongside recent calls outlining plans for its hybrid electric vertical takeoff and landing platform, puts fresh attention on how the company intends to fund development while managing dilution...
NasdaqGS:EWBC
NasdaqGS:EWBCBanks

A Look At East West Bancorp (EWBC) Valuation After Recent Share Price Momentum

Setting the scene for East West Bancorp (EWBC) East West Bancorp (EWBC) has drawn fresh attention after recent share price moves, with the stock around US$120.94 as investors weigh its banking footprint, profitability profile, and valuation signals. See our latest analysis for East West Bancorp. Recent trading has been fairly steady, with the latest 1 month share price return up 2.47%, while the 1 year total shareholder return of 31.49% and 3 year total shareholder return near 1.6x highlight...
NasdaqGS:IRTC
NasdaqGS:IRTCMedical Equipment

What iRhythm Holdings (IRTC)'s Sustained Zio Growth and 2027 AI Launch Plan Means For Shareholders

iRhythm Holdings recently reported its sixth consecutive quarter of over 20% growth, driven by its core Zio Monitor business, alongside improving profitability supported by automation and operating scale. The company also reaffirmed plans to launch its AI-enabled Zio MCT offering in the first half of 2027, underscoring its focus on efficiency and cost savings. We’ll now explore how iRhythm’s sustained growth and AI-enabled product roadmap may influence the company’s existing investment...
NasdaqGM:ALVO
NasdaqGM:ALVOBiotechs

Does Alvotech’s (ALVO) FDA Inspection Outcome Reframe Confidence in Its Biosimilar Strategy for 2026?

Earlier in May 2026, Alvotech reported that the FDA completed a routine cGMP surveillance inspection of its Reykjavik manufacturing facility, issuing a Form 483 that the company believes involves addressable observations and supports resubmission of key Biologics License Applications this quarter. Management is framing the inspection outcome as validation of the site’s quality improvements and as support for its expectation of FDA decisions on the relevant BLAs during 2026, a crucial pillar...
NasdaqGS:PATK
NasdaqGS:PATKAuto Components

Patrick Industries Renews Board As Dividends And Buybacks Face Cyclical Tests

Patrick Industries (NasdaqGS:PATK) held its annual shareholder meeting, electing a new board of directors and ratifying its auditor. Shareholders approved the latest executive compensation package. The company reaffirmed its focus on shareholder returns with a newly declared dividend and recent share buybacks. Patrick Industries enters this period of corporate housekeeping with its stock at $88.79 and a mixed recent track record. The share price is down 5.9% over the past week, down 17.0%...
NYSE:REZI
NYSE:REZIBuilding

Assessing Resideo Technologies (REZI) Valuation After A Sharp Pullback And ADI Separation Plans

Resideo Technologies (REZI) has been drawing fresh attention after recent share price moves, with the stock down 27% over the past week and about 33% lower over the past month. See our latest analysis for Resideo Technologies. Zooming out, the recent share price drop sits alongside a weaker short term trend, with the stock down over the past quarter, while the 1 year total shareholder return remains positive and suggests earlier gains are being reassessed. If sharp moves in home and building...
NYSE:DLR
NYSE:DLRSpecialized REITs

Is It Too Late To Reassess Digital Realty Trust (DLR) After This Year’s 20% Rally?

Investors may be wondering if Digital Realty Trust at about US$186 per share still offers value, or if most of the upside has already been priced in. The stock is up 20.2% year to date and 12.7% over the past year, even though it has fallen 4.6% over the last week and 8.5% over the last month. These moves can change how investors think about its risk and reward trade off. Recent attention on data center operators tied to artificial intelligence, along with ongoing discussion around funding...
NYSE:GGG
NYSE:GGGMachinery

Is Graco (GGG) Offering An Opportunity After Recent Share Price Weakness?

If you are wondering whether Graco's current share price lines up with its underlying value, this breakdown will help you connect the dots before you commit new capital. Graco's stock recently closed at US$75.32, with the share price down 2.3% over the past week, 13.2% over the last month and 12.0% over the past year, while edging up 1.6% over three years and 6.8% over five years. Recent coverage around Graco has focused on its position in the capital goods space and investor interest in how...
NasdaqGS:RGLD
NasdaqGS:RGLDMetals and Mining

Royal Gold Leans Into Royalty Model With Hod Maden Restructuring

Royal Gold restructured its interest in the Hod Maden Project, exchanging its direct ownership stake for a 2.5% net smelter return royalty. The transaction involved selling part of its equity stake to project partner Lidya Mines while retaining exposure through future royalty payments. This move reduces Royal Gold's exposure to project capital and operating costs and increases its focus on royalty based income. Royal Gold, ticker NasdaqGS:RGLD, recently experienced mixed share price...
NasdaqGS:EXPO
NasdaqGS:EXPOProfessional Services

A Look At Exponent (EXPO) Valuation After Strong Q1 Earnings And Recent Share Price Declines

Exponent (EXPO) is back in focus after its latest quarter, where revenue grew 10.5% year on year and topped forecasts by 1.8%, while earnings per share fell short and raised questions about profitability. See our latest analysis for Exponent. Since that earnings release, the stock’s 30 day share price return is down 16.25% and the year to date share price return is down 18.76%, while the 1 year total shareholder return has declined 26.98%. This points to fading momentum as investors reassess...
NasdaqGS:SYNA
NasdaqGS:SYNASemiconductor

Synaptics (SYNA) Valuation Check After Google I/O Edge AI Showcase And COMPUTEX Attention

Synaptics (SYNA) has attracted fresh attention after its Coralboard Edge AI platform, built with Google Research, featured at Google I/O 2026. This highlighted the company’s role in on-device AI and upcoming COMPUTEX Taipei presentations. See our latest analysis for Synaptics. Recent events around Coralboard at Google I/O and Synaptics’ COMPUTEX plans have coincided with a 54.13% 1 month share price return and a 90.22% 1 year total shareholder return, suggesting strong momentum built over...
NYSE:UAN
NYSE:UANChemicals

Assessing CVR Partners (UAN) Valuation After Icahn’s Bullish Move And Higher Cash Distribution

Carl Icahn’s renewed bullish stance on CVR Partners (UAN), along with increased ownership and a quarterly cash distribution nearly 80% higher than a year earlier, is pulling fresh investor attention to the nitrogen fertilizer producer. See our latest analysis for CVR Partners. The share price tells a mixed story, with a 17.44% 90 day share price return and a 24.95% year to date share price return. At the same time, the 1 year total shareholder return of 71.76% and 5 year total shareholder...
NYSE:AS
NYSE:ASLuxury

3 Stocks Estimated To Be Trading Below Intrinsic Value By 11.4% To 38.4%

Over the last 7 days, the United States market has experienced a slight decline of 1.0%, yet it remains up by an impressive 23% over the past year, with earnings forecasted to grow by 17% annually. In such a fluctuating environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervalued assets.
NasdaqGS:AVPT
NasdaqGS:AVPTSoftware

Spotlight On AvePoint And 2 Other Leading Growth Stocks With Insider Ownership

Over the last 7 days, the United States market has experienced a 1.0% drop, yet it remains up by 23% over the past year, with earnings projected to grow by 17% annually in the coming years. In this context of overall market growth and temporary fluctuations, stocks with high insider ownership can offer valuable insights into potential long-term performance as insiders' confidence may align their interests with those of other shareholders.
NasdaqCM:CRDF
NasdaqCM:CRDFBiotechs

Cardiff Oncology And 2 Other Promising Penny Stocks For Your Watchlist

Over the last 7 days, the U.S. market has dropped by 1.0%, yet it has risen by 23% over the past year, with earnings forecasted to grow annually by 17%. In such a fluctuating market, identifying stocks with strong fundamentals and growth potential is crucial for investors seeking stability and opportunity. While "penny stocks" may sound like an outdated term, they continue to represent smaller or less-established companies that can offer significant value; we've identified three such stocks...
NYSE:HTT
NYSE:HTTConsumer Finance

Discovering US Undiscovered Gems In May 2026

Over the last 7 days, the United States market has experienced a slight dip of 1.0%, yet it has shown impressive growth of 23% over the past year, with earnings anticipated to increase by 17% annually in the coming years. In such dynamic conditions, identifying lesser-known stocks with strong fundamentals and growth potential can offer unique opportunities for investors seeking to diversify their portfolios.
NasdaqGS:FFBC
NasdaqGS:FFBCBanks

A Look At First Financial Bancorp (FFBC) Valuation After Recent Mixed Return Performance

Recent performance snapshot First Financial Bancorp (FFBC) has drawn fresh attention after its recent share performance, with the stock last closing at $29.85 and showing mixed short term moves alongside stronger medium term total returns. Over the past day and week the stock slipped about 0.1% and 0.2%, while it inched higher over the past month and eased about 1.2% across the past 3 months. Longer horizons look different, with year to date and 1 year total returns of 18.97% and 24.64%, and...
NYSE:LNG
NYSE:LNGOil and Gas

Should Cheniere’s Q1 Loss and Ongoing Buybacks Prompt a Rethink From Cheniere Energy (LNG) Investors?

In May 2026, Cheniere Energy reported first-quarter 2026 results showing revenue of US$5,868 million but a net loss of US$3,502 million, and issued full-year 2026 net income guidance of US$0.10 billion to US$0.60 billion. At the same time, Cheniere continued to shrink its share count, having repurchased 54,408,478 shares since 2019, which equates to more than one-fifth of the company. We’ll now examine how the sharp swing to a quarterly net loss may affect Cheniere Energy’s previously...
NYSE:LEVI
NYSE:LEVILuxury

Levi Strauss Faces African Trade Uncertainty And Rising Labor Rights Pressures

Apparel industry groups linked to African manufacturing, including those involving Levi Strauss (NYSE:LEVI), are raising concerns about the instability created by short-term renewals of U.S. trade agreements with African countries. Unions are also calling for tighter labor-rights enforcement across African apparel supply chains, adding another layer of scrutiny for brands sourcing from the region. For Levi Strauss, which relies on a wide supplier base to support its denim and apparel...
NYSE:ZBH
NYSE:ZBHMedical Equipment

Is Zimmer Biomet’s Expanded US$1 Billion Buyback Reshaping the Investment Case for ZBH?

Earlier in May 2026, Zimmer Biomet Holdings announced it would increase its fiscal 2026 share repurchase expectations to as much as US$1.00 billion under a pre-existing US$1.50 billion authorization, alongside upcoming management presentations at a major healthcare conference. Set against recent insider selling disclosures and an updated 4.1% beneficial ownership filing from T. Rowe Price, the larger buyback plan highlights how capital allocation, ownership structure, and management...
NasdaqGM:AMAL
NasdaqGM:AMALBanks

How Investors Are Reacting To Amalgamated Financial (AMAL) Balancing Margin Gains With Slower Growth And Isolated Credit Issues

In recent months, Amalgamated Financial reported a solid first quarter with revenue rising year on year and topping analyst expectations, even as earnings per share and tangible book value per share came in below estimates and a single multifamily loan moved to nonaccrual. At the same time, the bank’s net interest margin improved over the past two years while overall revenue growth slowed, highlighting a shift toward more profitable core lending despite a moderating top line and isolated...
NasdaqGS:SFM
NasdaqGS:SFMConsumer Retailing

Sprouts Partners With Elmhurst Clean Protein As Valuation Gap Draws Attention

Sprouts Farmers Market (NasdaqGS:SFM) is serving as the national launch partner for Elmhurst 1925's Clean Protein plant-based beverages. The partnership introduces Elmhurst's Clean Protein line across Sprouts' stores, expanding its plant-based and health-oriented assortment. The rollout follows the recent BODi Shakeology launch at Sprouts, adding another premium, clean-label nutrition brand to its shelves. For investors watching the food retail space, Sprouts Farmers Market sits at the...
NYSE:KEYS
NYSE:KEYSElectronic

What Keysight Technologies (KEYS)'s Raised 2026 Growth Outlook on Record Q2 Results Means For Shareholders

In May 2026, Keysight Technologies reported record fiscal second-quarter results, with sales rising to US$1,717 million and net income reaching US$349 million, alongside higher earnings per share versus a year earlier. These results were underpinned by strong demand from AI data centers and other advanced test markets, prompting Keysight to lift its full-year 2026 revenue growth outlook to the high 20s percent range. With Keysight raising its 2026 growth outlook on robust AI and data center...